Trending Now
Atossa Therapeutics Inc. (NASDAQ: ATOS) Acknowledges Breast Cancer Awareness Month And...
Atossa Therapeutics Inc. (NASDAQ: ATOS) has released a video message acknowledging Breast Cancer Awareness Month and encouraging women to go for mammograms.
Pandemic affecting breast...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Dynavax Technologies Corporation (NASDAQ:DVAX) Partners with Medicago to Investigate and Evaluate...
Like many other companies, Dynavax Technologies Corporation (NASDAQ:DVAX) has embarked on a strategy to fight the COVID-19. The company is teaming up with Medicago...
MAKE IT MODERN
LATEST REVIEWS
Obseva SA (NASDAQ:OBSV) Reports, Topline Results from Phase 3 Studies of...
When it comes to menstruation, hundreds of women are suffering silently. A healthy and typical period should last between three to eight days. However,...
MAKE IT MODERN
PERFORMANCE TRAINING
Amicus Therapeutics (NASDAQ:FOLD) Announce Encouraging Preliminary AT-GTX-501 Gene Therapy Results In CNL6 Batten Disease
Amicus Therapeutics (NASDAQ:FOLD) has announced more positive preliminary data from the CLN6 Batten disease gene therapy program, AT-GTX-501.
Amicus presents AT-GTX-501 results
The released results were...
Curis, Inc. (NASDAQ: CRIS) Will Present Data on Its TakeAim Leukaemia and TakeAim Lymphoma...
Curis, Inc. (NASDAQ: CRIS) has announced that it will present encouraging data from its TakeAim Leukaemia and TakeAim Lymphoma trials at the American Society...
Looking for Growth? Why MMA Stocks Could be the Answer (EDR, BTDG, DKNG, WWE,...
According to a recent research report from Technavio, MMA is poised to become a potential juggernaut investment theme over coming years.
Acumen Pharmaceutical Inc (NASDAQ: ABOS) Issues an Update on Its Research on ACU193 Compound
Acumen Pharmaceutical Inc (NASDAQ: ABOS) recently announced the publication of a report that advocates for the use of ‘ACU193'. The compound is a monoclonal...
Amicus Therapeutics Inc. (NASDAQ:FOLD) Reports Q3 2020 Financial Results With Galafold Revenue Of $67.4...
Amicus Therapeutics Inc. (NASDAQ:FOLD) has announced its Q3 2020 financial results for the quarter ended September 30, 2020, in which Galafold revenue was $67.4...
MAKE IT MODERN
